Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3
The biokinetics of a size-selected fraction (70 nm median size) of commercially available and 48 V-radiolabeled [ 48 V]TiO 2 nanoparticles has been investigated in healthy adult female Wistar-Kyoto rats at retention time-points of 1 h, 4 h, 24 h, 7 d and 28 d after intratracheal instillation of a si...
Saved in:
Published in | Nanotoxicology Vol. 11; no. 4; pp. 454 - 464 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
01.05.2017
Taylor & Francis Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The biokinetics of a size-selected fraction (70 nm median size) of commercially available and
48
V-radiolabeled [
48
V]TiO
2
nanoparticles has been investigated in healthy adult female Wistar-Kyoto rats at retention time-points of 1 h, 4 h, 24 h, 7 d and 28 d after intratracheal instillation of a single dose of an aqueous [
48
V]TiO
2
-nanoparticle suspension. A completely balanced quantitative biodistribution in all organs and tissues was obtained by applying typical [
48
V]TiO
2
-nanoparticle doses in the range of 40-240 μg·kg
−1
bodyweight and making use of the high sensitivity of the radiotracer technique. The [
48
V]TiO
2
-nanoparticle content was corrected for residual blood retained in organs and tissues after exsanguination and for
48
V-ions not bound to TiO
2
-nanoparticles. About 4% of the initial peripheral lung dose passed through the air-blood-barrier after 1 h and were retained mainly in the carcass (4%); 0.3% after 28 d. Highest organ fractions of [
48
V]TiO
2
-nanoparticles present in liver and kidneys remained constant (0.03%). [
48
V]TiO
2
-nanoparticles which entered across the gut epithelium following fast and long-term clearance from the lungs via larynx increased from 5 to 20% of all translocated/absorbed [
48
V]TiO
2
-nanoparticles. This contribution may account for 1/5 of the nanoparticle retention in some organs. After normalizing the fractions of retained [
48
V]TiO
2
-nanoparticles to the fraction that reached systemic circulation, the biodistribution was compared with the biodistributions determined after IV-injection (Part 1) and gavage (GAV) (Part 2). The biokinetics patterns after IT-instillation and GAV were similar but both were distinctly different from the pattern after intravenous injection disproving the latter to be a suitable surrogate of the former applications. Considering that chronic occupational inhalation of relatively biopersistent TiO
2
-particles (including nanoparticles) and accumulation in secondary organs may pose long-term health risks, this issue should be scrutinized more comprehensively. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1743-5390 1743-5404 |
DOI: | 10.1080/17435390.2017.1306894 |